Viral immunotherapy extends lives of MD Anderson brain cancer patients – Houston Chronicle
Houston Chronicle |
Viral immunotherapy extends lives of MD Anderson brain cancer patients
Houston Chronicle Baskin's own research has produced what's thought to be the greatest single success in brain cancer viral immunotherapy – a glioblastoma patient who has now survived 11 years.Among the patients benefitting from MD Anderson's study was Phil Baumann, a … |
